DiaMedica Therapeutics Inc’s recently made public that its 10% Owner STAHLBERG JAN acquired Company’s shares for reported $2.03 million on Aug 25 ’25. In the deal valued at $6.00 per share,338,265 shares were bought. As a result of this transaction, STAHLBERG JAN now holds 7,654,045 shares worth roughly $49.06 million.
Then, STAHLBERG JAN bought 293,601 shares, generating $1,734,918 in total proceeds. Upon buying the shares at $5.91, the 10% Owner now owns 7,058,066 shares.
Before that, STAHLBERG JAN bought 70,414 shares. DiaMedica Therapeutics Inc shares valued at $421,921 were divested by the 10% Owner at a price of $5.99 per share. As a result of the transaction, STAHLBERG JAN now holds 7,128,480 shares, worth roughly $45.69 million.
A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. H.C. Wainwright began covering DMAC with “Buy” recommendation on October 07, 2024.
Price Performance Review of DMAC
On Monday, DiaMedica Therapeutics Inc [NASDAQ:DMAC] saw its stock jump 8.09% to $6.41. Over the last five days, the stock has gained 5.78%. DiaMedica Therapeutics Inc shares have risen nearly 50.47% since the year began. Nevertheless, the stocks have risen 18.05% over the past one year. While a 52-week high of $7.49 was reached on 09/08/25, a 52-week low of $3.19 was recorded on 04/07/25.
Levels Of Support And Resistance For DMAC Stock
The 24-hour chart illustrates a support level at 5.89, which if violated will result in even more drops to 5.38. On the upside, there is a resistance level at 6.83. A further resistance level may holdings at 7.26.
How much short interest is there in DiaMedica Therapeutics Inc?
A steep rise in short interest was recorded in DiaMedica Therapeutics Inc stocks on 2025-10-31, dropping by -0.12 million shares to a total of 4.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 4.24 million shares. There was a decline of -2.85%, which implies that there is a negative sentiment for the stock.
